NASDAQ: NVNO - enVVeno Medical Corporation

半年間の収益性: -37.87%
セクタ: Healthcare

プロモーションスケジュール enVVeno Medical Corporation

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

enVVeno Medical Corporation, a clinical med-tech company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021.

さらに詳しく
enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2018-05-31
ISIN US29415J1060
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.envveno.com
Цена ао 5.46
1日あたりの価格変動: +2.94% (3.06)
週ごとの価格変動: +26.51% (2.49)
月ごとの料金変更: -1.25% (3.19)
3ヶ月間の価格変動: -2.78% (3.24)
半年間の価格変動: -37.87% (5.07)
年間の価格変動: -38.72% (5.14)
3年間の価格推移: -52.99% (6.7)
5年間の価格推移: +479.04% (0.544)
10年間の価格推移: 0% (3.15)
年初からの価格変動: +1.61% (3.1)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 1.32 9
P/E 0 0
EV/EBITDA -2.39 0
合計: 3.63

効率

名前 意味 学年
ROA, % -48.35 0
ROE, % -50.9 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.0568 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % -96.06 0
収益性 Ebitda, % 279.06 10
収益性 EPS, % -84.2 0
合計: 6
さらに詳しく

機関 音量 共有, %
Nantahala Capital Management, LLC 1412638 10.61
Perceptive Advisors LLC 623315 4.68
Kingdon Capital Management LLC 619180 4.65
Armistice Capital, LLC 436000 3.27
Altium Capital Management, LP 344471 2.59
Vanguard Group Inc 336405 2.53
Rosalind Advisors, Inc. 312091 2.34
UBS OConnor LLC 236308 1.77
Velan Capital Investment Management LP 172235 1.29
Geode Capital Management, LLC 122116 0.92

ETF 共有, % 年間の利益率, % 配当金, %
iShares Micro-Cap ETF 0.01259 13.79 1.54048



スーパーバイザー 役職 支払い 生年
Mr. Robert A. Berman CEO & Director 1.02M 1963 (62 年)
Mr. Craig Thomas Glynn CFO, Treasurer & Secretary 313.69k 1961 (64 年)
Dr. Hamed Alavi Ph.D. Senior VP & Chief Technology Officer 384.39k
Dr. Marc H. Glickman M.D. Senior VP & Chief Medical Officer 491.59k 1949 (76 年)
Mr. Warren Hancock Co-founder N/A
Dr. Benedict Broennimann M.D. Chief Medical Officer of Outside of United States 240k 1957 (68 年)
Mr. Andrew Cormack Chief Commercial Officer N/A
Ms. Sandy Prietto Vice President of Marketing

住所: United States, Irvine. CA, 70 Doppler - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.envveno.com